Xenon gas successfully delivered to babies in ambulance

April 30, 2013, University of Bristol

(Medical Xpress)—Two babies at risk of brain injury following a lack of oxygen at birth have received xenon gas and cooling therapy while being transferred from one hospital to another in a specially equipped ambulance.

The first use of and in treating deprived of oxygen at birth took place at St Michael's Hospital in Bristol in 2010, but new technology now means that it can be delivered to babies while they are being transferred to St Michael's Hospital as part of a clinical trial.

The pioneering technique of delivering cooling and xenon gas to babies has been developed by Marianne Thoresen, Professor of Neonatal Neuroscience at the University of Bristol's School of Clinical Sciences and Dr John Dingley, Consultant Anaesthetist and Reader in at Swansea University's College of Medicine.

In the UK, every year, more than 1,000 otherwise healthy babies born at full term die or suffer caused by a lack of oxygen and/or at birth. This can lead to lifelong problems such as cerebral palsy.

Poppy Laker was the second baby in the world to receive xenon while being transferred between hospitals. When she was born at the Royal United Hospital in Bath she was not breathing and needed to be resuscitated. Her parents were told about the xenon trial and decided within 30 minutes to give permission for Poppy to have the treatment. Parents Stephen and Kelly Laker from Somerset said that the baby was doing well and has been taken off the and all medication and now simply has a feeding tube to help her eat.

Professor Marianne Thoresen said: "Xenon is a very rare and chemically inert anaesthetic gas found in tiny quantities in the air that we breathe. In 2002 Dr John Dingley and I realised the potential xenon and cooling might have in combination to further reduce disability. Over the past eight years, we have shown in the laboratory that xenon doubles the protective effect of cooling on the brain.

"Previously babies would need to come to us at St Michael's Hospital to have xenon gas treatment started, but we believe it is essential to start the xenon therapy as soon as possible after birth. As we work as part of a network, babies can come to us from Taunton to Swindon to Gloucester and often babies can't get back to us within five hours to start the treatment.

"Now, Dr Dingley has designed and built the equipment to commence delivery of the xenon to babies while they are still at the referring hospital and then while they are being transferred to St Michael's Hospital. Hopefully this will mean that more babies will have the opportunity to take part in the trial."

Dr Dingley has been developing equipment in Swansea for xenon anaesthesia in adults and more recently babies for over ten years. His machine takes the exhaled gas, removes waste products from it and re-circulates it to be breathed again without any loss to the outside air.

Dr John Dingley explained: "To reduce delay between birth and treatment it is now common to start cooling therapy during the ambulance transfer and we wanted to do this with the xenon as well. Therefore I developed a very compact version of the xenon breathing system we are using in the baby unit that fits a small space on the ambulance baby transport system so xenon can be delivered to the lungs continuously even while the baby is being moved. The system needs to recirculate all the breathed gases to contain costs as xenon is extremely expensive."

St Michael's Hospital and the University of Bristol has pioneered new treatments for brain injury in babies since Marianne Thoresen first started cooling babies in 1998, showing that cooling babies after a lack of oxygen could reduce damage in the newborn brain. After her original laboratory work from 1995 showing that cooling after reduced brain injury in animal models, clinical trials of cooling have now proven that mild cooling by only a few degrees for 72 hours is a safe and beneficial treatment. However, cooling only partially reduces disability and does not prevent it in all babies. The search has been to find a second treatment that could be added to cooling to further reduce disability. From 2010 to 2011, for the first time in the world, fourteen cooled infants at St Michael's Hospital took part in a study examining whether xenon could be delivered safely and without side effects. This was carried out successfully enabling ethical approval for the current study comparing xenon and cooling with the standard of cooling therapy on its own.

So far, 16 babies have taken part in this randomised controlled trial. Around half of them have had xenon and cooling and the other half the standard cooling therapy. The plan is to recruit 84 babies to the trial, the number predicted to be needed to show a difference between the two groups.

J P Moulton Charitable Trust said: "It is very gratifying to have part funded such exciting work. The team at Bristol are both talented and exceptionally dedicated."

John Shanley, Chief Executive for Sparks, added: "Each year in the UK, over 3,500 babies die before their first birthday. Funding research that helps prevent, diagnose, treat and cure conditions affecting the health of children is at the heart of what Sparks does. We have been committed to funding research into gas and cooling therapy for a number of years, and we are pleased to start seeing the outcomes of the wonderful work being done by Professor Thoresen and her team."

Explore further: Studying brain-cooling for birth asphyxia

Related Stories

Studying brain-cooling for birth asphyxia

March 21, 2013
In high income countries brain cooling is standard treatment for neonatal encephalopathy - unexpected, devastating brain injury due to low oxygen and blood in the baby's brain at birth. This therapy reduces mortality and ...

Enzyme controlling cell death paves way for treatment of brain damage in newborns

October 25, 2011
where the brain is starved of oxygen around the time of delivery – is normally treated by cooling the infant, but this only helps one baby in nine. New research from the Sahlgrenska Academy at the University of Gothenburg, ...

Recommended for you

Best of Last Year—The top Medical Xpress articles of 2017

December 20, 2017
It was a good year for medical research as a team at the German center for Neurodegenerative Diseases, Magdeburg, found that dancing can reverse the signs of aging in the brain. Any exercise helps, the team found, but dancing ...

Pickled in 'cognac', Chopin's heart gives up its secrets

November 26, 2017
The heart of Frederic Chopin, among the world's most cherished musical virtuosos, may finally have given up the cause of his untimely death.

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.